With Daylight Saving Time Approaching Fast, Learn Why Sleep Health is Important
- Details
- Written by Micah Dorfner
- Category: Health News
Mankato, Minnesota - Fall back, spring forward. We’ve all heard the saying, and it helps people remember which way to set their clocks for the start and end of Daylight Saving Time. Although it’d be nice to gain an hour of sleep twice a year, that’s not the case. Starting Sunday, March 8 at 2 a.m., we’ll all lose an hour. Altering your sleep schedule, or having poor sleep habits to begin with, can have a greater effect on your health than you may think.
Energy Drinks: Do They Really Boost Energy?
- Details
- Written by Katherine Zeratsky, R.D., L.D.
- Category: Health News
Rochester, Minnesota - Most energy drinks contain large amounts of caffeine, which can provide a temporary energy boost. Some energy drinks contain sugar and other substances. The boost is short-lived, however, and may be accompanied by other problems.
Fitting in fitness: Finding time for physical activity
- Details
- Written by Mayo Clinic
- Category: Health News
Scottsdale, Arizona - You know fitness is important for your health and well-being. And you want to get more active, but your days are a blur of work, household chores, errands, and time with family and friends. Setting aside enough time to sleep - let alone exercise - can be tough.
FDA authorizes use of first device to treat patients with dialysis-related amyloidosis
- Details
- Written by IVN
- Category: Health News
Washington, DC - The U.S. Food and Drug Administration today authorized use of Lixelle Beta 2-microglobulin Apheresis Column, the first device to treat dialysis-related amyloidosis (DRA).
FDA approves new antifungal drug Cresemba
- Details
- Written by IVN
- Category: Health News
Washington, DC - The U.S. Food and Drug Administration today approved Cresemba (isavuconazonium sulfate), a new antifungal drug product used to treat adults with invasive aspergillosis and invasive mucormycosis, rare but serious infections.
FDA approves first biosimilar product Zarxio
- Details
- Written by IVN
- Category: Health News
Washington, DC - The U.S. Food and Drug Administration today approved Zarxio (filgrastim-sndz), the first biosimilar product approved in the United States.
Page 3207 of 3785